| 1. | | Recruiting | UCN-01 (7-Hydroxystaurosporine) to Treat Relapsed T-Cell Lymphomas
Conditions: Lymphoma, Large-Cell, Ki-1; Lymphoma, T-Cell |
| 2. | | Recruiting | Tipifarnib in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions: adult non-Hodgkin's lymphoma; anaplastic large cell lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma; ... |
| 3. | | Recruiting | Study of SGN-30 (Antibody) in Patients with Refractory or Recurrent Hodgkin's Disease or Anaplastic Large Cell Lymphoma
Conditions: Hodgkin's Disease; Anaplastic Large-Cell Lymphoma |
| 4. | | Recruiting | Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin’s Lymphoma
Conditions: adult diffuse large cell lymphoma; anaplastic large cell lymphoma; angioimmunoblastic T-cell lymphoma; grade 3 follicular lymphoma |
| 5. | | Recruiting | Siplizumab in Treating Patients With Lymphoproliferative Disorder
Conditions: T-gamma lymphoproliferative disorder; adult T-cell leukemia and lymphoma; anaplastic large cell lymphoma; angioimmunoblastic T-cell lymphoma; ... |
| 6. | | Recruiting | Gemcitabine, Carboplatin, and Dexamethasone With or Without Rituximab in Treating Patients With Relapsed or Primary Refractory Lymphoma
Conditions: Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; anaplastic large cell lymphoma; angioimmunoblastic T-cell lymphoma; Cutaneous T-Cell Lymphoma; ... |
| 7. | | Recruiting | Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma
Conditions: adult Burkitt's lymphoma; adult diffuse large cell lymphoma; adult non-Hodgkin's lymphoma; anaplastic large cell lymphoma; Mantle Cell Lymphoma |
| 8. | | Not yet recruiting | Reduced-Intensity Regimen Before Allogeneic Bone Marrow Transplantation in Treating Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma
Conditions: adult Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; adult non-Hodgkin's lymphoma; anaplastic large cell lymphoma; ... |
| 9. | | Recruiting | Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
Conditions: adult T-cell leukemia and lymphoma; anaplastic large cell lymphoma; angioimmunoblastic T-cell lymphoma; Non-Hodgkin's Lymphoma |
| 10. | | Recruiting | FR901228 in Treating Patients With T-Cell Lymphoma
Conditions: adult non-Hodgkin's lymphoma; anaplastic large cell lymphoma; Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome |
| 11. | | Recruiting | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma
Conditions: adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult immunoblastic large cell lymphoma; anaplastic large cell lymphoma |
| 12. | | Recruiting | Comparison of Two Salvage Chemotherapy Regimens Before Autologous Stem Cell Transplantation With or Without Maintenance Rituximab in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Conditions: anaplastic large cell lymphoma; recurrent adult Burkitt's lymphoma; recurrent adult diffuse large cell lymphoma; angioimmunoblastic T-cell lymphoma |
| 13. | | Recruiting | Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: recurrent adult diffuse large cell lymphoma; recurrent adult immunoblastic large cell lymphoma; anaplastic large cell lymphoma |
| 14. | | Recruiting | Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse
Conditions: recurrent adult diffuse large cell lymphoma; anaplastic large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ... |
| 15. | | Recruiting | MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma
Conditions: recurrent adult Hodgkin's lymphoma; recurrent/refractory childhood Hodgkin's lymphoma; anaplastic large cell lymphoma; ... |
| 16. | | Recruiting | Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma
Condition: anaplastic large cell lymphoma |
| 17. | | Recruiting | BMS-247550 in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Conditions: recurrent grade 3 follicular lymphoma; recurrent adult diffuse large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ... |
| 18. | | Recruiting | Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: recurrent adult diffuse large cell lymphoma; recurrent adult Burkitt's lymphoma; recurrent mantle cell lymphoma; anaplastic large cell lymphoma |
| 19. | | Recruiting | Comparison of Combination Chemotherapy Regimens in Treating Children Who Have Anaplastic Large Cell Lymphoma
Conditions: stage I childhood large cell lymphoma; stage II childhood large cell lymphoma; stage III childhood large cell lymphoma; ... |
| 20. | | Recruiting | Monoclonal Antibody Therapy in Treating Patients With Refractory Anaplastic Large Cell Lymphoma or Hodgkin's Lymphoma
Conditions: recurrent adult Hodgkin's lymphoma; anaplastic large cell lymphoma |
| 21. | | Recruiting | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma
Conditions: recurrent grade 3 follicular lymphoma; recurrent adult diffuse small cleaved cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ... |
| 22. | | Not yet recruiting | Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer
Conditions: Cachexia; Cancer; Pain |
| 23. | | Recruiting | Epoetin alfa in Treating Cancer-Related Anemia in Patients With Non-Myeloid Cancer Who Are Not Currently Receiving Chemotherapy or Radiation Therapy
Conditions: adult solid tumor; Anemia; Leukemia; Lymphoma; plasma cell neoplasm |
| 24. | | Recruiting | 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas
Conditions: adult solid tumor; Leukemia; Lymphoma |
| 25. | | Recruiting | Decitabine in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas
Conditions: adult solid tumor; Leukemia; Lymphoma; small intestine cancer |
| 26. | | Recruiting | 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma
Conditions: adult solid tumor; Leukemia; Lymphoma; small intestine cancer |
| 27. | | Recruiting | Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma
Conditions: adult solid tumor; Leukemia; Lymphoma |
| 28. | | Recruiting | Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer
Conditions: adult solid tumor; fever, sweats, and hot flashes; hematopoietic and lymphoid cancer; Infection; Neutropenia |
| 29. | | Recruiting | Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
Conditions: adult solid tumor; Cachexia; Lymphoma |
| 30. | | Recruiting | Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction
Conditions: adult solid tumor; Leukemia; Lymphoma; small intestine cancer |
| 31. | | Recruiting | Phase I Study of HeFi-1 to Treat Cancers with CD30 Protein
Condition: Neoplasms |
| 32. | | Recruiting | CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy
Conditions: adult solid tumor; Leukemia; Lymphoma; small intestine cancer |
| 33. | | Recruiting | XK469 in Treating Patients With Advanced Solid Tumors or Lymphoma
Conditions: adult solid tumor; Leukemia; Lymphoma; small intestine cancer |
| 34. | | Recruiting | Combination Chemotherapy Followed by Donor Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Genetic Disorders
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; plasma cell neoplasm |
| 35. | | Recruiting | Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: Langerhans cell histiocytosis; childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer |
| 36. | | Recruiting | Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated with the Epstein Barr Virus
Conditions: Cancer; grade I lymphomatoid granulomatosis; grade II lymphomatoid granulomatosis; recurrent grade I lymphomatoid granulomatosis; ... |
| 37. | | Recruiting | BMS-247550 in Treating Patients With Advanced Cancers
Conditions: adult solid tumor; Leukemia; Lymphoma; small intestine cancer |
| 38. | | Recruiting | Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment
Conditions: adult solid tumor; Leukemia; Lymphoma; small intestine cancer |
| 39. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma
Condition: Cancer |
| 40. | | Recruiting | 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
Conditions: chronic myeloproliferative disorders; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm |
| 41. | | Recruiting | Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma
Conditions: adult solid tumor; Leukemia; Lymphoma; small intestine cancer |
| 42. | | Recruiting | Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Aplastic Anemia or Hematologic Cancer
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer |
